Search Results - "Tamez‐Torres, Karla M."
-
1
Clinical and Microbiological Characteristics of Febrile Neutropenia During Induction Chemotherapy in Adults With Acute Leukemia
Published in Cancer reports (01-08-2024)“…ABSTRACT Background Few studies regarding infectious causes of febrile neutropenia (FN) in Mexico are available. Aims We aimed to describe clinical and…”
Get full text
Journal Article -
2
Metabolomics analysis identifies glutamic acid and cystine imbalances in COVID-19 patients without comorbid conditions. Implications on redox homeostasis and COVID-19 pathophysiology
Published in PloS one (20-09-2022)“…It is well known that the presence of comorbidities and age-related health issues may hide biochemical and metabolic features triggered by SARS-CoV-2 infection…”
Get full text
Journal Article -
3
Outcomes of patients with severe and critical COVID-19 treated with dexamethasone: a prospective cohort study
Published in Emerging microbes & infections (01-12-2022)“…Dexamethasone implementation for COVID-19 management represented a milestone but data regarding its impact and safety have not been consistently reproduced. We…”
Get full text
Journal Article -
4
Antimicrobial Resistance Patterns and Antibiotic Use during Hospital Conversion in the COVID-19 Pandemic
Published in Antibiotics (Basel) (11-02-2021)“…To describe empirical antimicrobial prescription on admission in patients with severe COVID-19, the prevalence of Hospital-Acquired Infections, and the…”
Get full text
Journal Article -
5
Cephalotin Versus Dicloxacillin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteraemia: A Retrospective Cohort Study
Published in Antibiotics (Basel) (01-02-2024)“…First-line treatments for methicillin-susceptible (MSSA) bacteraemia are nafcillin, oxacillin, or cefazolin. Regional shortages of these antibiotics force…”
Get full text
Journal Article -
6
Effect of Tocilizumab in Mortality among Patients with Severe and Critical Covid-19: Experience in a Third-Level Medical Center
Published in Revista de investigacion clinica (01-01-2022)“…Trials evaluating safety and efficacy of tocilizumab in coronavirus disease 19 (COVID-19) show contradictory results. The objective of the study was to…”
Get full text
Journal Article -
7
Safety and Tolerability of Six Months of Isoniazid Plus Pyridoxine or Three Months of Rifampicin for Tuberculosis among Subjects with Diabetes Mellitus: A Randomized Trial
Published in Microorganisms (Basel) (28-07-2023)“…Tuberculosis (TB) associated with diabetes mellitus (DM) is a growing problem, particularly in low- and medium-resource countries. We conducted an open-label,…”
Get full text
Journal Article -
8
Predictors of poor outcomes in young non-comorbid patients with COVID-19
Published in Revista de investigacion clinica (2022)“…BackgroundPrognostic factors in previously healthy young patients with COVID-19 remained understudied. ObjectivesThe objective of the study was to identify…”
Get full text
Journal Article -
9
Large-scale screening for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) among healthcare workers: Prevalence and risk factors for asymptomatic and pauci-symptomatic carriers, with emphasis on the use of personal protective equipment (PPE)
Published in Infection control and hospital epidemiology (01-04-2022)“…Healthcare workers (HCWs) not fulfilling the coronavirus disease 2019 (COVID-19) case definition underwent severe acute respiratory coronavirus virus 2…”
Get full text
Journal Article -
10
High prevalence of MDR gram-negative bacteria in feces of healthy blood donors in Mexico
Published in European journal of clinical microbiology & infectious diseases (01-08-2020)“…During the initial stage of a study to recruit universal intestinal microbiota donors in Mexico City, we found multiple “healthy” subjects that colonized with…”
Get full text
Journal Article -
11
Early Outpatient Treatment With Remdesivir in Patients at High Risk for Severe COVID-19: A Prospective Cohort Study
Published in Open forum infectious diseases (01-10-2022)“…BackgroundEarly treatment of coronavirus disease 2019 (COVID-19) with remdesivir in high-risk patients, including those with immunosuppression of different…”
Get full text
Journal Article -
12
CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS OF PATIENTS DIAGNOSED WITH COVID-19 IN A TERTIARY CARE CENTER IN MEXICO CITY: A PROSPECTIVE COHORT STUDY
Published in Revista de investigacion clinica (2020)“…Regional information regarding the characteristics of patients with coronavirus disease (COVID)-19 is needed for a better understanding of the pandemic. The…”
Get full text
Journal Article -
13
Cephalotin Versus Dicloxacillin for the Treatment of Methicillin-Susceptible IStaphylococcus aureus/I Bacteraemia: A Retrospective Cohort Study
Published in Antibiotics (Basel) (01-02-2024)“…Background: First-line treatments for methicillin-susceptible S. aureus (MSSA) bacteraemia are nafcillin, oxacillin, or cefazolin. Regional shortages of these…”
Get full text
Journal Article -
14
283. Post COVID-19 syndrome and quality of life impairment in a cohort of severe COVID-19
Published in Open forum infectious diseases (15-12-2022)Get full text
Journal Article -
15
Metabolomics analysis identifies glutamic acid and cystine imbalances in COVID-19 patients without comorbid conditions. Implications on redox homeostasis and COVID-19 pathophysiology
Published in PloS one (01-01-2022)“…It is well known that the presence of comorbidities and age-related health issues may hide biochemical and metabolic features triggered by SARS-CoV-2 infection…”
Get full text
Journal Article -
16
Nirmatrelvir/ritonavir and remdesivir against symptomatic treatment in high-risk COVID-19 outpatients to prevent hospitalization or death during the Omicron era: a propensity score-matched study
Published in Therapeutic advances in infectious disease (01-01-2024)“…Plain language summary Nirmatrelvir/ritonavir and remdesivir against symptomatic treatment in high-risk COVID-19 outpatients In this study, we included…”
Get full text
Journal Article